Measurement-based care with PHQ-9 at baseline and monthly; SSRI as first-line pharmacotherapy with 4–6 week adequate trial; switch or augment if inadequate response; offer evidence-based psychotherapy alongside medication.
Authored pathway active · depression-in-adults.outpatient
Measurement-based care with PHQ-9 at baseline and monthly; SSRI as first-line pharmacotherapy with 4–6 week adequate trial; switch or augment if inadequate response; offer evidence-based psychotherapy alongside medication.
Guidelines: APA 2024 Practice Guideline for Major Depressive Disorder · VA/DoD 2024 Clinical Practice Guideline for MDD · NICE NG222 Depression in Adults (2022 + 2024 updates)
Phenotypes (3)
- Mild-Moderate Depression in Adults
- Moderate-Severe Depression in Adults
- Treatment-Resistant Depression
Pathway-scoped symptom and exam intake
Test this pathway's ROS and differential links
Uses LR engine psych.depression.core.v1, then routes suggested engines into the workspace.
19-panel workspace
depression-in-adults · OutpatientStart patient workup
Open a scratch or linked encounter, add active problems, then keep labs, fluids, acid-base, and electrolyte tools beside the main workspace instead of losing context.
Encounter and problems
No encounter open. Add a problem to create a scratch encounter when none is open.
Multi-window tools
Unified
labs + fluids + acid-base
Labs
fast lab analyzer
Fluid
resuscitation and balance
Electrolytes
Na/K/Mg/Phos/Ca
ABG/VBG
compensation and mixed disorders
Popular entry points
6 quick-startsOr jump straight to the atlas
The Engine Atlas covers every authored disease package with setting chips and pathway badges. Open any engine to load its 19-panel workspace, backed by phenotype-aware reasoning and monitored by the Flow Assistant.